G1 Therapeutics, Inc. GTHX
7.16 0.00 (+0.00%)
Sep 17, 2024, 3:56 PM EDT
7.14 Day range 7.16
52-week range unavailable
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2023 · select a line to chart its full history
Income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 82.51M | 51.30M | 31.48M | 45.28M | 0 | |
| 75.32M | 47.55M | 29.46M | 45.28M | 0 | |
| -39.53M | -136.18M | -142.46M | -96.48M | -129.04M | |
| -47.97M | -147.56M | -148.35M | -99.25M | -122.45M | |
| -0.93 | -3.38 | -3.54 | -2.62 | -3.27 |
Balance sheet
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 32.47M | 94.91M | 221.56M | 207.81M | 269.71M | |
| 121.54M | 187.97M | 254.09M | 228.55M | 284.83M | |
| 86.15M | 119.22M | 110.55M | 51.20M | 29.30M | |
| 55.90M | 82.63M | 81.94M | 27.76M | 9.54M | |
| 35.39M | 68.75M | 143.54M | 177.35M | 255.53M |
Cash flow
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -38.34M | -128.62M | -132.11M | -83.74M | -99.57M | |
| 2.81M | -50.53M | 0 | 152.00K | -2.72M | |
| -26.91M | 52.49M | 145.86M | 21.69M | 2.71M | |
| -62.44M | -126.65M | 13.76M | -61.90M | -99.58M |